CORINNA HANSEN: Open Payments
NPI 1578016838 · NORFOLK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 26 payments from 7 companies in 2025. Trend: 2023 $551 · 2024 $406 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $143 |
| Novo Nordisk Inc | 8 | $136 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| ABBVIE INC. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Astellas Pharma US Inc | 1 | $17 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
Products named: REXULTI, Wegovy, Ozempic, QULIPTA, Kerendia, AIRSUPRA, Veozah, ACTHAR.
Industry payments across NE — which companies pay providers there.
